Skip to content

Leukocyte- and Platelet-Rich Fibrin for preventing Osteoradionecrosis following Tooth Extraction

Leukocyte- and Platelet-Rich Fibrin for Preventing Osteoradionecrosis following Tooth Extraction: an exploratory study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8y49vf
Enrollment
Unknown
Registered
2018-07-02
Start date
2018-07-31
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoradionecrosis

Interventions

Test group: 16 subjects previously submitted to radiotherapy for head and neck cancer will receive leukocyte- and platelet-rich fibrin to fill and cover postextraction sockets. Control group: 16 subje
Other

Sponsors

Universidade Ibirapuera
Lead Sponsor
Hospital Heliópolis
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Previous 3D conformational radiotherapy for head and neck cancer; total radiotherapy dose from 50Gy to 70Gy; at least 18 years of age; able to undergo dental surgery.

Exclusion criteria

Exclusion criteria: Disease recurrence (cancer); drugs that impact on tissue repair, healing processes (hard and/or soft tissues), and blood coagulation; diseases that impact on tissue repair, healing processes (hard and/or soft tissues), and blood coagulation; tobacco use; radiotherapy for head and neck cancer more than once.

Design outcomes

Primary

MeasureTime frame
To assess the potential effect of Leukocyte- and platelet-rich fibrin on preventing the development of tooth extraction related-osteoradionecrosis sites in patients previously submitted to head and neck cancer radiotherapy

Secondary

MeasureTime frame
To evaluate the potential effect of Leukocyte- and platelet-rich fibrin on reducing pain (assessed via visual analogue scale) and other complications of tooth extraction (clinical features) in patients previously submitted to radiotherapy for head and neck cancer

Countries

Brazil

Contacts

Public ContactLuiz Palma

Universidade Ibirapuera

luizfelipep@hotmail.com+55(11)56947900

Outcome results

None listed

Source: REBEC (via WHO ICTRP)